Research shows a new cause of Parkinson’s Disease

Credit: Unsplash+

Millions of people around the world are affected by Parkinson’s Disease, a progressive condition where brain cells deteriorate over time.

This leads to various difficulties including problems with movement, thinking, and sometimes even dementia.

Parkinson’s is one of the most common neurodegenerative diseases, second only to Alzheimer’s.

For many years, scientists have struggled to understand what exactly causes Parkinson’s Disease, which has made finding effective treatments challenging.

However, recent research from the University of Copenhagen has brought a new and exciting breakthrough to light.

The researchers have identified a crucial problem in a pathway that affects the mitochondria—the small structures within cells that produce energy.

When this pathway malfunctions, it stops cells from being able to remove damaged mitochondria. This leads to a shortage of energy and an accumulation of harmful proteins, which ultimately results in the death of brain cells.

An important aspect of this discovery is the role of immune genes, which are typically involved in protecting us from viruses but also play a critical role in maintaining energy balance in nerve cells.

When these genes do not function properly, it can cause the mitochondria to become less effective at generating energy, contributing to the development of Parkinson’s Disease.

The study also linked these pathways to our body’s ability to fight infections, such as COVID-19.

The researchers found that certain genetic mutations related to these pathways could worsen the effects of COVID-19, connecting the health of our nerve cells to our immune response against viruses.

Professor Shohreh Issazadeh-Navikas and her team conducted detailed examinations of gene expression in the brains of individuals with Parkinson’s compared to those without the condition.

They noticed that the accumulation of damaged mitochondria led to an increase in toxic proteins in the brain. One protein, in particular, PIAS2, was found in higher levels in those with Parkinson’s and could potentially serve as a marker for diagnosing the disease.

The implications of these findings are significant because they not only enhance our understanding of Parkinson’s but also open up new avenues for treatment.

By targeting the identified pathway, there might be a possibility to halt the progression of Parkinson’s and prevent the onset of dementia associated with it.

The researchers believe that further investigation into how this pathway functions in different types of Parkinson’s could reveal more strategies to combat this debilitating disease.

Their study, published in the journal Molecular Psychiatry, offers hope to those suffering from Parkinson’s Disease.

By uncovering how the regulation of mitochondria affects neuron health, the study moves us closer to treatments that might alleviate symptoms or even stop the disease before it fully develops.

With ongoing research building on these findings, the prospects for managing Parkinson’s Disease in the future are becoming more promising.

This groundbreaking research not only deepens our understanding of Parkinson’s Disease but also illustrates the interconnectedness of our body’s systems—from energy production to immune defense—highlighting the intricate balance essential for our overall health.

If you care about Parkinson’s disease, please read studies about Vitamin E that may help prevent Parkinson’s disease, and Vitamin D could benefit people with Parkinson’s disease.

For more information about brain health, please see recent studies about new way to treat Parkinson’s disease, and results showing COVID-19 may be linked to Parkinson’s disease.

Copyright © 2024 Knowridge Science Report. All rights reserved.